Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited.

Putter H, Schumacher M, van Houwelingen HC.

Biom J. 2020 Mar 4. doi: 10.1002/bimj.201800274. [Epub ahead of print]

PMID:
32128860
2.

Assessment of heterogeneity in an individual participant data meta-analysis of prediction models: An overview and illustration.

Steyerberg EW, Nieboer D, Debray TPA, van Houwelingen HC.

Stat Med. 2019 Sep 30;38(22):4290-4309. doi: 10.1002/sim.8296. Epub 2019 Aug 2.

3.

Commentary to the paper by Walter Dempsey and Peter McCullagh.

van Houwelingen HC.

Lifetime Data Anal. 2018 Oct;24(4):595-600. doi: 10.1007/s10985-018-9444-5. Epub 2018 Jul 18. No abstract available.

4.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM.

Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13.

PMID:
29908991
5.

Understanding Landmarking and Its Relation with Time-Dependent Cox Regression.

Putter H, van Houwelingen HC.

Stat Biosci. 2017;9(2):489-503. doi: 10.1007/s12561-016-9157-9. Epub 2016 Jul 11.

6.

Testing interaction between treatment and high-dimensional covariates in randomized clinical trials.

Callegaro A, Spiessens B, Dizier B, Montoya FU, van Houwelingen HC.

Biom J. 2017 Jul;59(4):672-684. doi: 10.1002/bimj.201500194. Epub 2016 Oct 20.

PMID:
27763683
7.

Dynamic frailty models based on compound birth-death processes.

Putter H, van Houwelingen HC.

Biostatistics. 2015 Jul;16(3):550-64. doi: 10.1093/biostatistics/kxv002. Epub 2015 Feb 13.

PMID:
25681608
8.

The role of empirical Bayes methodology as a leading principle in modern medical statistics.

van Houwelingen HC.

Biom J. 2014 Nov;56(6):919-32. doi: 10.1002/bimj.201400073. Epub 2014 Sep 10.

PMID:
25205521
9.

From model building to validation and back: a plea for robustness.

van Houwelingen HC.

Stat Med. 2014 Dec 30;33(30):5223-38. doi: 10.1002/sim.6282. Epub 2014 Aug 6.

PMID:
25100164
10.

Comparison of stopped Cox regression with direct methods such as pseudo-values and binomial regression.

van Houwelingen HC, Putter H.

Lifetime Data Anal. 2015 Apr;21(2):180-96. doi: 10.1007/s10985-014-9299-3. Epub 2014 Aug 2. Review.

PMID:
25084763
11.

Validation, calibration and refitting of a familial breast cancer model in sisterships: a case study in the Swedish sisters data.

van Houwelingen HC, Rebora P, Reilly M.

Stat Med. 2013 Sep 10;32(20):3486-500. doi: 10.1002/sim.5781. Epub 2013 Mar 18.

PMID:
23508778
12.

Vertical modelling: Analysis of competing risks data with missing causes of failure.

Nicolaie MA, van Houwelingen HC, Putter H.

Stat Methods Med Res. 2015 Dec;24(6):891-908. doi: 10.1177/0962280211432067. Epub 2011 Dec 16.

PMID:
22179822
13.

Frailties in multi-state models: Are they identifiable? Do we need them?

Putter H, van Houwelingen HC.

Stat Methods Med Res. 2015 Dec;24(6):675-92. doi: 10.1177/0962280211424665. Epub 2011 Nov 23.

PMID:
22116343
14.

Modelling the effect of baseline risk in meta-analysis: a review from the perspective of errors-in-variables regression.

Ghidey W, Stijnen T, van Houwelingen HC.

Stat Methods Med Res. 2013 Jun;22(3):307-23. doi: 10.1177/0962280211412244. Epub 2011 Sep 8. Review.

PMID:
21908417
15.

Sensitivity analysis of state-transition models: how to deal with a large number of inputs.

van Houwelingen HC, Boshuizen HC, Capannesi M.

Comput Biol Med. 2011 Sep;41(9):838-42. doi: 10.1016/j.compbiomed.2011.07.001. Epub 2011 Jul 23.

16.

Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial.

Vos MS, Putter H, van Houwelingen HC, de Haes HC.

Lung Cancer. 2011 Apr;72(1):119-24. doi: 10.1016/j.lungcan.2010.07.007. Epub 2010 Aug 11.

PMID:
20705356
17.

Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.

Schuurhof A, Bont L, Siezen CL, Hodemaekers H, van Houwelingen HC, Kimman TG, Hoebee B, Kimpen JL, Janssen R.

Pediatr Pulmonol. 2010 Jun;45(6):608-13. doi: 10.1002/ppul.21229.

PMID:
20503287
18.

Dealing with heterogeneity between cohorts in genomewide SNP association studies.

Lebrec JJ, Stijnen T, van Houwelingen HC.

Stat Appl Genet Mol Biol. 2010;9:Article 8. doi: 10.2202/1544-6115.1503. Epub 2010 Jan 13.

PMID:
20196758
19.

Vertical modeling: a pattern mixture approach for competing risks modeling.

Nicolaie MA, van Houwelingen HC, Putter H.

Stat Med. 2010 May 20;29(11):1190-205. doi: 10.1002/sim.3844.

PMID:
20099244
20.

Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modeling.

Lebrec JJ, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, van Houwelingen HC.

BMC Proc. 2009 Dec 15;3 Suppl 7:S94.

21.

Comparing and ranking hospitals based on outcome: results from The Netherlands Stroke Survey.

Lingsma HF, Steyerberg EW, Eijkemans MJ, Dippel DW, Scholte Op Reimer WJ, Van Houwelingen HC; Netherlands Stroke Survey Investigators.

QJM. 2010 Feb;103(2):99-108. doi: 10.1093/qjmed/hcp169. Epub 2009 Dec 11.

22.

Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds.

Hamza TH, Arends LR, van Houwelingen HC, Stijnen T.

BMC Med Res Methodol. 2009 Nov 10;9:73. doi: 10.1186/1471-2288-9-73.

23.

Commentary on 'Measurement in clinical trials: a neglected issue for statisticians?'.

van Houwelingen HC.

Stat Med. 2009 Nov 20;28(26):3218-9; discussion 3223-5. doi: 10.1002/sim.3654. No abstract available.

PMID:
19842098
24.

Assessment of global phase uncertainty in case-control studies.

Uh HW, Houwing-Duistermaat JJ, Putter H, van Houwelingen HC.

BMC Genet. 2009 Sep 14;10:54. doi: 10.1186/1471-2156-10-54.

25.

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.

Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, Hoogerbrugge N, Ligtenberg M, Ausems MG, van der Luijt RB, Dommering CJ, Gille JJ, Verhoef S, Hogervorst FB, van Os TA, Gómez García E, Blok MJ, Wijnen JT, Helmer Q, Devilee P, van Asperen CJ, van Houwelingen HC.

BMC Cancer. 2009 Jun 29;9:211. doi: 10.1186/1471-2407-9-211.

26.

Denial and physical outcomes in lung cancer patients, a longitudinal study.

Vos MS, Putter H, van Houwelingen HC, de Haes HC.

Lung Cancer. 2010 Feb;67(2):237-43. doi: 10.1016/j.lungcan.2009.04.003. Epub 2009 May 6.

PMID:
19423181
27.

Score test for age at onset genetic linkage analysis in selected sibling pairs.

Callegaro A, van Houwelingen HC, Houwing-Duistermaat JJ.

Stat Med. 2009 Jun 30;28(14):1913-26. doi: 10.1002/sim.3596.

PMID:
19402027
28.

Associating explanatory variables with summary receiver operating characteristic curves in diagnostic meta-analysis.

Hamza TH, van Houwelingen HC, Heijenbrok-Kal MH, Stijnen T.

J Clin Epidemiol. 2009 Dec;62(12):1284-91. doi: 10.1016/j.jclinepi.2009.02.002. Epub 2009 Apr 23.

PMID:
19398297
29.

Global tests for linkage.

el Galta R, van Houwelingen HC, Houwing-Duistermaat JJ.

Biom J. 2009 Feb;51(1):70-83. doi: 10.1002/bimj.200810492.

PMID:
19197957
30.

A polygenic model for integration of linkage and pathway information.

Lebrec JJ, Nishchenko I, van der Wijk HJ, Huizinga TW, van Houwelingen HC.

Genet Epidemiol. 2009 Apr;33(3):198-206. doi: 10.1002/gepi.20370.

PMID:
18979499
31.

Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data.

van Houwelingen HC, Putter H.

Lifetime Data Anal. 2008 Dec;14(4):447-63. doi: 10.1007/s10985-008-9099-8. Epub 2008 Oct 3.

32.

Combining matched and unmatched control groups in case-control studies.

le Cessie S, Nagelkerke N, Rosendaal FR, van Stralen KJ, Pomp ER, van Houwelingen HC.

Am J Epidemiol. 2008 Nov 15;168(10):1204-10. doi: 10.1093/aje/kwn236. Epub 2008 Oct 3.

PMID:
18836151
33.

Denial in lung cancer patients: a longitudinal study.

Vos MS, Putter H, van Houwelingen HC, de Haes HC.

Psychooncology. 2008 Dec;17(12):1163-71. doi: 10.1002/pon.1325.

PMID:
18823062
34.

Influence of genotyping error in linkage mapping for complex traits--an analytic study.

Lebrec JJ, Putter H, Houwing-Duistermaat JJ, van Houwelingen HC.

BMC Genet. 2008 Aug 25;9:57. doi: 10.1186/1471-2156-9-57.

35.

Adjusting for sex and anti-CCP levels in linkage analysis of rheumatoid arthritis.

Lebrec JJ, Helmer Q, Nishchenko I, van Houwelingen HC.

BMC Proc. 2007;1 Suppl 1:S75. Epub 2007 Dec 18.

36.

A new score statistic to test for association given linkage in affected sibling pair-control designs.

Houwing-Duistermaat JJ, Uh HW, van Houwelingen HC.

BMC Proc. 2007;1 Suppl 1:S39. Epub 2007 Dec 18.

37.

Model selection based on logistic regression in a highly correlated candidate gene region.

Uh HW, Mertens BJ, Jan van der Wijk H, Putter H, van Houwelingen HC, Houwing-Duistermaat JJ.

BMC Proc. 2007;1 Suppl 1:S114. Epub 2007 Dec 18.

38.

Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models.

Fiocco M, Putter H, van Houwelingen HC.

Stat Med. 2008 Sep 20;27(21):4340-58. doi: 10.1002/sim.3305.

PMID:
18425994
39.

The comparative analysis of statistics, based on the likelihood ratio criterion, in the automated annotation problem.

Leontovich AM, Tokmachev KY, van Houwelingen HC.

BMC Bioinformatics. 2008 Jan 22;9:31. doi: 10.1186/1471-2105-9-31.

40.

The binomial distribution of meta-analysis was preferred to model within-study variability.

Hamza TH, van Houwelingen HC, Stijnen T.

J Clin Epidemiol. 2008 Jan;61(1):41-51. Epub 2007 Aug 23.

PMID:
18083461
41.

[Early surgery or a wait-and-see policy in lumbosacral radicular syndrome: a randomized study].

Peul WC, Van Houwelingen HC, Van den Hout WB, Brand R, Eekhof JA, Tans JT, Thomeer RT, Koes BW.

Ned Tijdschr Geneeskd. 2007 Nov 10;151(45):2512-23. Dutch.

PMID:
18062596
42.

Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis.

Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, van Houwelingen HC, Derksen RH, Berden JH.

Nephrol Dial Transplant. 2008 Jan;23(1):223-30. Epub 2007 Nov 2.

PMID:
17981886
43.

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.

Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van 't Slot R, Wijmenga C, Goeman JJ, Kimpen JL, van Houwelingen HC, Kimman TG, Hoebee B.

J Infect Dis. 2007 Sep 15;196(6):826-34. Epub 2007 Aug 10.

PMID:
17703412
44.

Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

Grootscholten C, Snoek FJ, Bijl M, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party of SLE.

J Rheumatol. 2007 Aug;34(8):1699-707. Epub 2007 Jul 15.

PMID:
17659757
45.

Analysis of multiple SNPs in genetic association studies: comparison of three multi-locus methods to prioritize and select SNPs.

Heidema AG, Feskens EJ, Doevendans PA, Ruven HJ, van Houwelingen HC, Mariman EC, Boer JM.

Genet Epidemiol. 2007 Dec;31(8):910-21.

PMID:
17615573
46.

Surgery versus prolonged conservative treatment for sciatica.

Peul WC, van Houwelingen HC, van den Hout WB, Brand R, Eekhof JA, Tans JT, Thomeer RT, Koes BW; Leiden-The Hague Spine Intervention Prognostic Study Group.

N Engl J Med. 2007 May 31;356(22):2245-56.

47.

The denial of cancer interview: development and first assessment of psychometric properties in lung cancer patients.

Vos MS, Putter H, Leurs A, Rooijmans HG, de Haes HC, van Houwelingen HC.

Patient Educ Couns. 2007 Jul;67(1-2):224-34. Epub 2007 May 11.

PMID:
17498908
48.

Score test for linkage in generalized linear models.

Lebrec JJ, van Houwelingen HC.

Hum Hered. 2007;64(1):5-15. Epub 2007 Apr 27.

PMID:
17483592
49.

An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?

de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP, Vandenbroucke JP.

Clin Infect Dis. 2007 May 1;44(9):1143-9. Epub 2007 Mar 26.

PMID:
17407029
50.

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.

Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Arthritis Rheum. 2007 Mar;56(3):924-37.

Supplemental Content

Loading ...
Support Center